INTRODUCTION
============

Metastasis to the ovaries occurs in 0.8%--7.4% of colorectal cancer cases in women.^[@ref1])^ In the presence of ovarian metastasis, the prognosis of colorectal cancer is poor. Metachronous ovarian metastasis occurs in 0.1%--4% of cases^[@ref2]-[@ref7])^ and is mostly identified within 3 years.^[@ref6])^ We experienced a rare case of a patient with cecal cancer and synchronous ovarian metastasis who developed metachronous preserved ovarian metastasis identified 8 years after initial surgery. In this case, complete resection was achieved two times.

CASE PRESENTATION
=================

A 64-year-old Japanese woman presented to the Department of Gynecology of Aichi Cancer Center Hospital (Nagoya, Aichi Prefecture, Japan) with a 2-month history of abdominal bloating. An imaging study detected swelling of the right ovary with ascites, which led to suspicion of a primary ovarian neoplasm and cancerous peritonitis ([Fig. 1A](#fig1){ref-type="fig"}). No malignant cells were detected in the ascites. An exploratory laparotomy was performed, which detected a right ovarian tumor and cecum tumor. Barium enema X-ray inspection performed before surgery failed to detect the tumor. There was no evidence of peritoneal dissemination, thus, a right oophorectomy was performed. The right ovary measured 10 × 7.3 × 6.5 cm and was histologically diagnosed as an adenocarcinoma ([Fig. 1B](#fig1){ref-type="fig"}, [C](#fig1){ref-type="fig"}). After surgery, a total colonoscopy in association with biopsy confirmed a diagnosis of cecum colon cancer. As a result, a diagnosis of unilateral ovarian metastasis from colon cancer was made.

###### 

Preoperative image, the resected specimen, and histological findings of the first laparotomy

**Fig. 1A:**Computed tomography demonstrated a swollen right ovary (arrow) with ascites.

**Fig. 1B:** The resected right ovary measured 10 × 7.3 × 6.5 cm.

**Fig. 1C:** Histologically, the right ovary contained a solid lesion and a cystic lesion. In the solid lesion, adenocarcinoma composed of tall columnar cells was revealed. The tumor was suspected to have metastasized from colorectal cancer.
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One month later, right hemicolectomy with regional lymph node dissection (D2) was performed. The pathological diagnosis was of a well-differentiated adenocarcinoma (T3/SS, tub1, ly1, v1, infβ, N0 (0/29)). The macroscopic and histological findings are shown in [Fig. 2A](#fig2){ref-type="fig"}, [B](#fig2){ref-type="fig"}. The patient received S-1 chemotherapy for 4 years. No recurrence was detected during the follow-up period.

###### 

The resected specimen and histological findings of the second laparotomy.

**Fig. 2A:** Macroscopic view of the cecal cancer (arrow)

**Fig. 2B:** The pathological diagnosis was well-differentiated adenocarcinoma.
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After 8 years, the patient presented with vaginal bleeding and abdominal bloating. A computed tomography (CT) scan revealed a pelvic mass approximately 10 cm in diameter, but no mass was evident on a CT image taken 6 months before ([Fig. 3A](#fig3){ref-type="fig"}, [B](#fig3){ref-type="fig"}). Blood tests showed progressive anemia (hemoglobin, 9.6 g/dl) and a high level of the tumor marker carcinoembryonic antigen (26.0 ng/ml). The patient was diagnosed with left ovarian metastasis from colon cancer. A third laparotomy revealed a left ovarian tumor but no evidence of other metastasis or peritoneal dissemination. Left oophorectomy was performed. The left ovary measured 12 × 11 × 3 cm and was pathologically diagnosed as an adenocarcinoma consistent with metastasis of colon cancer ([Fig. 4 A](#fig4){ref-type="fig"}, [B](#fig4){ref-type="fig"}). Immunohistochemistry confirmed cytokeratin 7 (CK-7) negativity, cytokeratin 20 (CK-20) positivity, caudal-type homeobox transcription factor 2 (CDX2) positivity, and paired box protein-8 (PAX8) negativity ; findings consistent with a metachronous colon cancer metastasis to the ovary ([Fig. 5A](#fig5){ref-type="fig"}, [B](#fig5){ref-type="fig"}, [C](#fig5){ref-type="fig"}, [D](#fig5){ref-type="fig"}, [E](#fig5){ref-type="fig"}).

###### 

reoperative images of the third laparotomy.

**Fig. 3A:** A CT scan taken 6 months before surgery showed that the size of the left ovary was normal.

**Fig. 3B:** The left ovary was recognized as a 10-cm pelvic mass on a CT scan taken just before surgery.
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###### 

The resected specimen and histological findings of the third laparotomy

**Fig. 4A:** The resected left ovary measured 12 × 11 × 3 cm.

**Fig. 4B:** The histological diagnosis was adenocarcinoma consistent with metastasis of colon cancer.
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![Immunohistochemistry of the left ovary\
**Fig. 5A:** Hematoxylin and eosin staining\
**Fig. 5B:** Immunohistochemical stains for CK-7 ; the tumor cells are negative.\
**Fig. 5C:** Immunohistochemical stains for CK-20 ; the tumor cells are positive.\
**Fig. 5D:** Immunohistochemical stains for CDX2 ; the tumor cells are positive.\
**Fig. 5E:** Immunohistochemical stains for PAX8 ; the tumor cells are negative.\
These stain pattern were consistent with that in colon cancer.\
In ovarian epithelium (arrow in each figure), stain pattern was different from that in tumor cells.](2186-3326-79-0259-g005){#fig5}

S-1 chemotherapy was started again 1 month after surgery. Nine years after initial surgery, peritoneal metastasis was found, which was treated with modified infusional intravenous fluorouracil and levofolinate with oxaliplatin. At the time of writing, tumor progression is being controlled.

DISCUSSION
==========

The incidence of ovarian metastases from colorectal cancer is estimated at 3%--14%.^[@ref6])^ Ovarian metastases occur in about 0.8%--7.4% of all colorectal cancer cases in women.^[@ref1])^ In Japan, synchronous metastases from colorectal cancer to other organs also occurs---liver (10.9% patients), peritoneum (4.5%), lung (2.4%), and other organs (1.9%).^[@ref8])^ Among the 5230 cases that underwent curative resection of colon cancer, metastases occurred in 906 (17.3%). Metastases to the liver occurred in 7.1% of cases, to the lung in 4.8%, recurred locally in 4.0%, to the anastomosis site in 0.4%, and to other organs in 3.8%.^[@ref8])^ These data suggest that ovarian metastases are not rare.

Metachronous metastases from colorectal cancer at or after 5 years from the initial surgery reportedly occur in 0.63% of cases.^[@ref8])^ Kim *et al.* reported that 82.8% of metachronous ovarian metastases occurred within 3 years.^[@ref6])^ In the present case, metachronous ovarian metastasis was identified 8 years after the initial surgery, which is relatively rare.

The metastatic pathways of ovarian tumors have not yet been established. The present case showed no evidence of peritoneal dissemination at laparotomy, no lymphatic metastasis on pathological findings, and no recurrence for 8 years. Therefore, the main route of ovarian metastasis in this case may have been hematogenous spread.

In the presence of ovarian metastasis, metastasis of colorectal cancer is usually extensive and is considered to have a poor prognosis. Morrow *et al.* reported that in their study, about half of the cases of metachronous ovarian metastasis occurred with peritoneal metastasis, with a 5-year survival rate of 0%.^[@ref9])^ Suzuki *et al.* also reported a mean survival time of ovarian metastases of 21.3 months.^[@ref10])^

Erroi *et al.* reported that the overall survival at 3 years of 10 patients after radical oophorectomy for isolated ovarian metastases was 80%.^[@ref11])^ Tomiki *et al.* reported 5-year survival rates of 29.1% for 26 cases of ovarian metastases from colorectal cancer and 67.5% in 10 cases of isolated ovarian metastases.^[@ref12])^ Our patient is alive 10 years after the initial surgery.

These data demonstrate that oophorectomy can prolong survival in cases of isolated ovarian metastases from colorectal cancer. In many recent reports, bilateral oophorectomy at the time of surgery for colorectal cancer without macroscopic ovarian metastases was found to be unwarranted.^[@ref2],[@ref13])^ However, 43--70% of ovarian metastases occur to the bilateral ovaries,^[@ref6])^ and some studies have reported metastasis to the preserved ovary after unilateral oophorectomy, as with the present case.^[@ref13])^

Complete resection for metastasis to the preserved ovary was achieved in the present case. Yamaguchi *et al.* reported two cases with severe clinical symptoms and metastasis to the preserved ovary, but the general condition of these patients contraindicated additional laparotomy.^[@ref13])^ Therefore, in cases of ovarian metastases from colorectal cancer without other extensive metastases, bilateral oophorectomy should be performed. If the premenopausal patient requires preservation of hormonal and reproductive functions by performing unilateral oophorectomy, a strict follow-up is necessary to detect any metachronous recurrence in the preserved ovary. The findings in this case suggest that if there is no recurrence for 5 years after unilateral oophorectomy, follow-up should be continued.

CONCLUSIONS
===========

We experienced a case of metachronous left ovarian metastasis 8 years after surgery for cecal cancer and right ovarian metastasis. In cases of isolated ovarian metastasis from colorectal cancer, oophorectomy is associated with a survival benefit. If metastasis from colon cancer is identified in a unilateral ovary, prophylactic bilateral oophorectomy should be performed. When unilateral oophorectomy is performed, a strict and long-term follow-up is mandatory.
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